BRUSSELS (BELGIUM) – Germany’s health minister Jens Spahn told EU lawmakers on Monday that the country has only a few hundred doses of COVID-19 antiviral remdesivir. The minister urged them to shift the production of the drug to Europe.
“We do not have a huge inventory now, (it’s) a few hundred doses that we have,” he said at a video-conference.
Spahn said he was looking at ways to ensure the medicine is produced in Europe. Currently, its manufacturer Gilead Sciences Inc has no production facilities for the drug in Europe.
(Photos syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field
